These findings suggest that during renal fibrosis, GAS5 expression is suppressed within renal tissue, leading to reduced deposition in tissue; simultaneously, due to impaired renal function, the excretion of GAS5 in urine decreases, resulting in elevated plasma GAS5 levels. The gene discussed is GAS5; the disease is renal fibrosis.